Company intelligence / Profile preview

Fujian Huitian Bio-Pharma

Fuzhou, Fujian, China

Ownership: Private
Employees: ~500
Development stage: Other

Overview

Fujian Huitian Bio-Pharma is a large, established Chinese pharmaceutical manufacturer with a diverse portfolio spanning Western medicines, traditional Chinese medicines, APIs, generics, and select innovative drugs. It holds several exclusive national varieties and secret recipes within China. Its commercialized portfolio includes over eighty drug specifications across seven dosage forms. The company supplies both domestic and export markets with APIs such as loxoprofen and benazepril hydrochloride.

Therapeutic areas: Infectious DiseasesRheumatologyCardiovascularOther
Modalities: Small moleculeBiologic (including biological agents)Traditional Chinese medicine (TCM) productsPeptidesAPI supplier
Industry: Pharma

Beyond the preview

Go deeper on Fujian Huitian Bio-Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fujian Huitian Bio-Pharma.

Explore the full profile